Genespire
Developing transformative gene therapies for people affected by genetic diseases
$52M Series B+ ·
Led by CDP Venture Capital · Source: fundraisingfox.com
Total raised: $69.35M across 2 sourced rounds
All 2 rounds ↓Signals
Genespire | 201 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $52M | fundraisingfox.com | ||
| Series A | $17.35M | finsmes.com |
Timeline
- Website created
Founders and team
AC
Alessio Cantore co-founderLinkedIn · source: genespire.comLN
Luigi Naldini co-founder@NaldiniLab · source: genespire.comKP
Karen Pignet-Aiach CEOJB
Julia Berretta Chief Executive OfficerJS
Julianne Smith Chief Development OfficerLF
Lucia Faccio Chief Executive OfficerPM
Philippe Mauberna Chief Financial OfficerSS
Sabah Sallah Chief Medical Officer
Investors
CCDP Venture Capitallead investor
IIndaco Venture Partners
SSofinnova Partnerslead investor
XXGEN Venturelead investor
Companies like Genespire
AAddition Therapeutics$100M Series A · Dec 2025
SSplice Bio$140M Series B+ · Jun 2025
TTune Therapeutics$175M Series B+ · Jan 2025
SSpecific Biologics$35M Series A · Nov 2026
AAlia Therapeutics$5M Seed · Apr 2023
PPhlox TherapeuticsSeed · Dec 2024
Other companies backed by CDP Venture Capital
NNouscom$135.04M Series B+ · Oct 2026
TTrueLayer$27M Series B+ · Oct 2026
AAptadir Therapeutics$45M Seed · Sep 2026
CClastix$3.3M Seed · Sep 2026
FFermLabs$3.47M Seed · Sep 2026
PProxima Fusion$468M Series B+ · Jul 2026
CDP Venture Capital portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/genespire (get a free API key).